This therapeutic approach not only effectively facilitates the expression of IL-15, but also significantly enhances intracellular reactive oxygen species (ROS) levels, induces immunogenic cell death (ICD), thereby effectively suppressing tumor growth and recurrence. This evidence concerns the gene IL15 and neoplasm.